8-K: Align Technology Reports Q4 and Fiscal Year 2024 Results: Revenue and Volume Growth Offset by Forex Headwinds

Align Technology announced its Q4 and fiscal year 2024 results, showcasing revenue and volume growth, but also highlighting the impact of unfavorable foreign exchange rates.

Summary

• Align Technology reported Q4 2024 total revenues of $995.2 million, a 4.0% increase year-over-year.
• Fiscal year 2024 total revenues reached $4.0 billion, up 3.5% compared to the previous year.
• Q4 Clear Aligner volumes increased by 6.1% year-over-year and 1.9% sequentially.
• Q4 Systems and Services revenues saw a significant increase of 14.9% year-over-year and 5.2% sequentially.
• The company's 2024 operating margin was 15.2%, while the non-GAAP operating margin was 21.8%.
• Diluted net income per share for 2024 was $5.62, and non-GAAP diluted net income per share was $9.33.
• Foreign exchange rates negatively impacted 2024 total revenues by approximately $38.5 million.
• During Q4 2024, Align repurchased $202.9 million of its common stock, with an average price of $222.94 per share.
• Align expects Q1 2025 worldwide revenues to be in the range of $965 million to $985 million.
• The company anticipates low single-digit year-over-year revenue growth for fiscal year 2025.
• Capital expenditures for fiscal year 2025 are projected to be between $100 million and $150 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While the company reports growth in key areas, it also acknowledges the negative impact of foreign exchange rates and provides a cautious outlook for the coming year. The management's comments are generally optimistic, but the presence of risks and challenges tempers the overall sentiment.

Positives

• Q4 Clear Aligner volume was up 1.9% sequentially and up 6.1% year-over-year.
• Q4 Imaging Systems and CAD/CAM Services revenues were up 5.2% sequentially and up 14.9% year-over-year.
• The company concluded the year with no debt and approximately $1,044 million in cash and cash equivalents.
• Align was listed as one of the top 300 companies worldwide that were granted U.S. patents last year on the 2025 Patent 300 list, with Align ranked at #263 with 164 U.S. patents granted in 2024.
• Align's Invisalign Palatal Expander System has been listed on the Singapore Medical Device Register as a class B medical device.

Negatives

• Foreign exchange rates negatively impacted 2024 total revenues by approximately $38.5 million.
• Q424 diluted net income per share was unfavorably impacted by a stronger U.S. dollar, which amounted to approximately $0.14 per diluted share due to net foreign exchange losses related to the revaluation of certain balance sheet accounts.
• The company expects Q125 GAAP operating margin to be below Q124 GAAP operating margin by approximately 2 points, primarily due to unfavorable foreign exchange at current spot rates.
• The company expects Q125 non-GAAP operating margin to be below Q124 non-GAAP operating margin by approximately 1 point, primarily due to unfavorable foreign exchange at current spot rates.

Risks

• Fluctuations in currency exchange rates could continue to impact revenue and profitability.
• Potential imposition of tariffs on goods shipped from Mexico to the U.S. could increase costs.
• A tougher consumer demand environment in China could affect sales.
• The company faces competition from existing and new competitors.
• Unexpected changes in the growth or decline of domestic and/or international markets could impact performance.

Future Outlook

Align expects low single-digit year-over-year revenue growth for fiscal year 2025, with Clear Aligner volume growth up approximately mid-single digits. They anticipate Systems and Services revenues to grow faster than Clear Aligner revenues. The company also expects a GAAP operating margin of approximately 17.0% and a non-GAAP operating margin of approximately 22.5% for fiscal year 2025.

Management Comments

• Align Technology President and CEO Joe Hogan stated that Q4 total revenues, Clear Aligner volumes, and Systems and Services revenues were in line with the company's Q4 outlook.
• Align Technology CFO and EVP Global Finance, John Morici, expressed satisfaction with the company's Q4 and fiscal 2024 results, highlighting Clear Aligner volume growth and operating margin improvement.
• John Morici stated that the company's goal is to deliver value to its shareholders.

Industry Context

Align Technology's focus on digital orthodontics and restorative dentistry positions it well within the evolving dental industry. The company's expansion into new markets and its continued innovation in clear aligner technology and intraoral scanners demonstrate its commitment to maintaining a competitive edge.

Comparison to Industry Standards

• Align Technology competes with companies like Straumann, Dentsply Sirona, and Envista Holdings in the dental and orthodontic markets.
• Align's growth in Systems and Services revenues, particularly with iTero scanners, is a key differentiator compared to competitors primarily focused on consumables.
• The company's investment in research and development, as evidenced by its patent rankings, is crucial for maintaining its technological leadership.
• Align's operating margins are generally strong compared to industry averages, but are impacted by foreign exchange fluctuations.

Management Changes

Related Party Transactions

• During the quarter, Align completed a $30.0 million equity investment in Smile Doctors, the largest ortho-focused dental support organization in the U.S.

Stakeholder Impact

• Shareholders: The company's financial performance and stock repurchase program could impact shareholder value.
• Employees: Restructuring actions taken in Q4 to improve profitability could affect employees.
• Customers: Planned price increases for Clear Aligners in certain regions could impact customers.
• Doctors: The release of new products and enhancements to existing products could impact doctors.

Next Steps

• The company will host a conference call on February 5, 2025, to review the results and discuss future operating trends.
• Align plans to raise the list price of Clear Aligners by approximately 3% on average in the Americas and EMEA regions on March 1, 2025.
• The company expects the commercial availability of its iTero Lumina scanner with restorative software at the end of March.

Key Dates